Litcius/Paper detail

Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants

Sumin Han, P Lee, Hyo‐Jick Choi

2023Pharmaceutics10 citationsDOIOpen Access PDF

Abstract

Given the limitations of conventional invasive vaccines, such as the requirement for a cold chain system and trained personnel, needle-based injuries, and limited immunogenicity, non-invasive vaccines have gained significant attention. Although numerous approaches for formulating and administrating non-invasive vaccines have emerged, each of them faces its own challenges associated with vaccine bioavailability, toxicity, and other issues. To overcome such limitations, researchers have created novel supplementary materials and delivery systems. The goal of this review article is to provide vaccine formulation researchers with the most up-to-date information on vaccine formulation and the immunological mechanisms available, to identify the technical challenges associated with the commercialization of non-invasive vaccines, and to guide future research and development efforts.

Topics & Concepts

ImmunogenicityMedicineCommercializationRisk analysis (engineering)Intensive care medicineImmunologyBusinessImmune systemMarketingImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiology
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants | Litcius